SCHEMBL10281027

SCHEMBL10281027

Bc1cccc(C(=C)C=C)c1

nearest known ligand 0.34

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ AKT1 P31749 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25649498 0.77 AKT1 (0.40) AKT1
SCHEMBL12831681 0.75 CES2 (0.52) —
SCHEMBL12802064 0.75 TDP1 (0.52) —
SCHEMBL21417238 0.75 F2 (0.48) AKT1
SCHEMBL12095541 0.75 TP53 (0.52) AKT1
SCHEMBL12449810 0.75 APP (0.36) AKT1
SCHEMBL14046813 0.74 L3MBTL1 (0.36) —
SCHEMBL108144 0.72 AKT1 (0.54) AKT1
SCHEMBL20934481 0.72 UNG (0.36) AKT1
SCHEMBL23015482 0.71 PTGS1 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2307372-B1 HETEROCYCLIC ANTIVIRAL COMPOUNDS HOFFMANN LA ROCHE (CH) 2012-04-25 — — EP disclosed
Send feedback